Professional photo of Dr. Loice Ombajo, Co-Director at CEMA

Dr. Loice Ombajo

Co-Director

Co-Founder & Team Lead (Clinical Research)

Quick Facts

Co-Founder & Team Lead (Clinical Research)
Clinical Research
M.Med in Internal Medicine

Dr. Loice Ombajo is a Physician and Infectious Disease Specialist. Loice is also a Senior Lecturer in Internal Medicine at the University of Nairobi and an Adjunct Assistant Professor of Medicine at the University of Texas Medical Branch. She heads the Infectious Diseases Unit at the Kenyatta National Hospital and is the chair of the KNH antimicrobial stewardship committee at the National Antimicrobial Stewardship Interagency Technical committee where she heads the technical working group on antimicrobial use. She also offers clinical expertise to various HIV treatment failure technical working groups. During the COVID-19 outbreak, she has offered leadership at KNH in clinical care, mentorship and training of clinicians around the country responding to consults on patient care from all over the country. She has sat in the COVID-19 national task force offering advisory on the national response to both the National Emergency Response Committee and the National task force, has led the writing of the COVID- 19 National case management guidelines, the IPC guidelines, the HRH guidelines, the testing protocols etc Also leading various research to inform the case management of COVID-19. Has played a key role in public education on various platforms including TV, radio and newspapers.

Publications

Showing 1-5 of 15 publications

Wellcome Open Research2025

A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA)

Wellcome Open Research2025-05-25T00:00:00.000Z

Dr. Loice Ombajo
2025

Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir Trial

Dr. Loice Ombajo, Dr. Joseph Nkuranga +3 more
HIVDolutegravir
Springer Nature Link2025

Reserve antibiotics: overcoming limitations of evidence generated from regulatory approval trials

Springer Nature Link2025-04-03T00:00:00.000Z

Dr. Loice Ombajo
antibioticsAMR
IJID regions2024

Investigation and successful control of a Candida auris outbreak at a tertiary health care facility in Kenya

Ombajo Loice Achieng, Kanyua Alice, Ngugi Rose, Malcolm Correia, Berkow Elizabeth, Gade Lalitha, Bancroft Elizabeth, Osoro Joan, Njoroge Rachel, Juma Phoebe, Ngirita Margaret, Bore Rose Cheptoo, Litvintseva Anastasia, Lyman Meghan, Toda Mitsuru. "Investigation and successful control of a ". IJID regions. (2024 Dec)

IJID regions2024-12-01T00:00:00.000Z

Dr. Loice Ombajo
HIV medicine2024

High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with HIV.

Penner Jeremy, Ombajo Loice A, Nkuranga Joseph, Otieno Edwin, Nyakoe Diana, Wanjohi Ruth, Mbewa Victor, Ndinya Florentius, Eshiwani Sheila, Wahome Simon, Bhagani Sanjay, Pozniak Anton, Gregson Celia L. "High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with HIV.". HIV medicine. (2025 Mar)

HIV medicine2024-11-21T00:00:00.000Z

Dr. Loice Ombajo, Dr. Joseph Nkuranga +2 more